In the present study a series of tetrahydroisoquinoline derivatives were synthesized and evaluated for their activity towards three ABC transporters, P-gp, MRP1 and BCRP. The compounds proved to be selective against P-gp. One of them, 8b, displayed activity in the nanomolar range (EC50 = 94 nM). Thus, compound 8b was tested for its ability to restore the cytotoxic activity of a well-known anti-cancer agent and P-gp substrate, doxorubicin, as first proof of concept. Moreover, compound 8b was also tested in an in vitro model of competent gastro-intestinal (GI) barrier (Caco-2 cells) for its ability to inhibit P-gp, present on luminal side, and increase the apical-to-basolateral transport of several structurally uncorrelated drugs, belonging to different therapeutic areas but actively excreted by P-gp. Notably the transport of the drugs across the GI barrier was increased by a concentration of 8b devoid of toxicity and of perturbing effects on barrier function. An in vitro simulated digestion process was set up: interestingly the effect of 8b on the transport of digoxin was preserved also after the simulated digestion process. This result may suggest 8b as a safe and effective P-gp modulator that can increase the bioavailability of a wide spectrum of drugs administered per os, improving their transport across the GI barrier.

One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells

Guglielmo S.;Riganti C.;Antonello G.;Rolando B.;Fruttero R.;
2020

Abstract

In the present study a series of tetrahydroisoquinoline derivatives were synthesized and evaluated for their activity towards three ABC transporters, P-gp, MRP1 and BCRP. The compounds proved to be selective against P-gp. One of them, 8b, displayed activity in the nanomolar range (EC50 = 94 nM). Thus, compound 8b was tested for its ability to restore the cytotoxic activity of a well-known anti-cancer agent and P-gp substrate, doxorubicin, as first proof of concept. Moreover, compound 8b was also tested in an in vitro model of competent gastro-intestinal (GI) barrier (Caco-2 cells) for its ability to inhibit P-gp, present on luminal side, and increase the apical-to-basolateral transport of several structurally uncorrelated drugs, belonging to different therapeutic areas but actively excreted by P-gp. Notably the transport of the drugs across the GI barrier was increased by a concentration of 8b devoid of toxicity and of perturbing effects on barrier function. An in vitro simulated digestion process was set up: interestingly the effect of 8b on the transport of digoxin was preserved also after the simulated digestion process. This result may suggest 8b as a safe and effective P-gp modulator that can increase the bioavailability of a wide spectrum of drugs administered per os, improving their transport across the GI barrier.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
208
112843
112860
Bioavailability; Drug design; Gastro-intestinal barrier; Multi-drug resistance; Oral administration; P-glycoprotein
Contino M.; Guglielmo S.; Riganti C.; Antonello G.; Perrone M.G.; Giampietro R.; Rolando B.; Fruttero R.; Colabufo N.A.
File in questo prodotto:
File Dimensione Formato  
Contino, EJMC Ms and Supporting, 2020.pdf

non disponibili

Descrizione: Contino, EJMC 2020
Tipo di file: PDF EDITORIALE
Dimensione 4.2 MB
Formato Adobe PDF
4.2 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
manuscript_22_luglio.docx

non disponibili

Descrizione: Contino, EJMC Open Access pre-print 2020
Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 1.54 MB
Formato Microsoft Word XML
1.54 MB Microsoft Word XML   Visualizza/Apri   Richiedi una copia
manuscript_22_luglio.pdf

accesso aperto

Descrizione: Contino, EJMC Open Access pre-print 2020
Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 809.31 kB
Formato Adobe PDF
809.31 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1765848
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact